Aminothiazole derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8637557
APP PUB NO 20120220767A1
SERIAL NO

13502636

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A compound represented by formula (1) or a pharmaceutically acceptable salt thereof, which has a PI3 kinase γ inhibitory effect and is useful as a prophylactic or therapeutic agent for articular rheumatism, Crohn's disease, irritable colitis, Sjoegren's syndrome, multiple sclerosis, systemic lupus erythematosus, asthma, atopic dermatitis, arteriosclerosis, organ transplant rejection, cancer, retinopathy, psoriasis, arthrosis deformans, age-related macular degeneration, type II diabetes, insulin resistance, obesity, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hyperlipemia, etc.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAISHO PHARMACEUTICAL CO LTD24-1 TAKADA 3-CHOME TOSHIMA-KU TOKYO 1708633 ?1708633

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kuroda, Shoichi Tokyo, JP 8 24
Oi, Takahiro Tokyo, JP 12 85
Oka, Yusuke Tokyo, JP 22 70
Sekiguchi, Yoshinori Tokyo, JP 23 103
Yabuuchi, Tetsuya Tokyo, JP 11 88

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 28, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00